David Kirn
President and Chief Executive Officer, Director · 4D Molecular Therapeutics, Inc.
- 2026
- Oct 7, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Kirn files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Scott Bizily - $364K in FDMT purchases and sales in the last 12 months
- Ashoo Gupta - $7K in FDMT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Kirn?
David Kirn is a corporate insider, tracked as President and Chief Executive Officer, Director of 4D Molecular Therapeutics, Inc. (FDMT). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Kirn submitted recently?
5 primary Form 4 filings in the last 90 days, covering 1 company.
Has David Kirn been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($5.01M) across all tracked filings.
